References
- van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28:2845-55. DOI: 10.1007/s00330-017-5246-5
- Dong M, Jiao Z, Liu T, Guo F, Li G. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. J Nephrol. 2012;25:290-301. DOI: 10.5301/jn.5000067
- Mouton R, Holder K. Laboratory tests of renal function. Anaesthesia & Intensive Care Medicine 2006;7:240-3. DOI: 10.1053/j.mpaic.2006.04.003
- Hošková L, Franekova J, Málek I, Kautzner J, Szárszoi O, Jabor A, et al. Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. Ann Transplant. 2016;21:329-245. DOI: 10.12659/AOT.896700
- Liu Z, Shang A, Chen Z, Yin L, Qi H. Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans. Medicine. 2020;99:e21386. DOI: 10.1097/MD.0000000000021386
- Zhang W-F, Zhang T, Ding D, Sun S-Q, Wang X-L, Chu S-C, et al. Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Contrast-Induced Acute Kidney Injury and Its Clinical Implications. J Am Heart Assoc. 2017;6:e004747. DOI: 10.1161/JAHA.116.004747
- Endre ZH, Walker RJ. Chapter Eleven - Biomarkers of Cardiovascular Risk in Chronic Kidney Disease. In: Edelstein CL, editor. Biomarkers of Kidney Disease (Second Edition), Academic Press. 2017, p. 485-511. DOI: 10.1016/B978-0-12-803014-1.00011-X
- Breglia A, Godi I, Virzì GM, Guglielmetti G, Iannucci G, De Cal M, et al. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography. Cardiorenal Med. 2020;10:125-36. DOI: 10.1159/000505422
- Petrova I, Alexandrov A, Vladimirov G, Mateev H, Bogov I, Paskaleva I, et al. NGAL as Biomarker of Clinical and Subclinical Damage of Kidney Function after Coronary Angiography. Diagnostics (Basel). 2023;13:1180. DOI: 10.3390/diagnostics13061180
- Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent Renal Damage After Contrast-Induced Acute Kidney Injury. Circulation. 2012;125:3099-107. DOI: 10.1161/CIRCULATIONAHA.111.085290
- Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542-8. DOI: 10.1016/S0735-1097(00)00917-7
- McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-75. DOI: 10.1016/S0002-9343(97)00150-2
- Malavasi VL, Valenti AC, Ruggerini S, Manicardi M, Orlandi C, Sgreccia D, et al. Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome. J Clin Med. 2022;11:891. DOI: 10.3390/jcm11030891
- Shacham Y, Leshem-Rubinow E, Steinvil A, Assa E Ben, Keren G, Roth A, et al. Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study. Clin Res Cardiol. 2014;103:525-32. DOI: 10.1007/s00392-014-0680-8
- Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 2014;85:513-21. DOI: 10.1038/ki.2013.374
- Lupu L, Abukatash H, Banai A, Rozenfeld K-L, Lewit D, Merdler I, et al. Relation of Baseline Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Contrast-Induced Nephropathy following Percutaneous Coronary Intervention among Chronic Kidney Disease Patients. J Clin Med. 2021;10:5403. DOI: 10.3390/jcm10225403
- Ogedegbe HO. Renal Function Tests: A Clinical Laboratory Perspective. Lab Med. 2007;38:295-304. DOI: 10.1309/RWG5DY7RG1CYBUR7
- Briguori C, Visconti G, Rivera N V, Focaccio A, Golia B, Giannone R, et al. Cystatin C and Contrast-Induced Acute Kidney Injury. Circulation. 2010;121:2117-22. DOI: 10.1161/CIRCULATIONAHA.109.919639
- Wacker-Gußmann A, Bühren K, Schultheiss C, Braun SL, Page S, Saugel B, et al. Prediction of Contrast-Induced Nephropathy in Patients With Serum Creatinine Levels in the Upper Normal Range by Cystatin C: A Prospective Study in 374 Patients. AJR Am J Roentgenol. 2014;202:452-8. DOI: 10.2214/AJR.13.10688